Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance
1 other identifier
interventional
12
1 country
1
Brief Summary
Study title Camel Milk Impact on Aerobic Exercise Recovery, Induced Inflammation, and Physical Performance Investigator Dr. Mo'ath Bataineh Department of Nutrition and Health College of Medicine \& Health Sciences United Arab Emirates University Brief Summary This study aims to examine the effects of post-exercise camel milk consumption on recovery and subsequent high-intensity cycling performance in recreationally trained adult males. The primary objective is to determine whether camel milk improves time to exhaustion and overall workload compared with cow's milk or water. Secondary objectives include assessing its impact on muscle soreness, muscle damage, and inflammatory markers following intense exercise. Participants are healthy, non-obese males over 18 years of age with no milk allergies and not using antioxidant supplements, anti-inflammatory drugs, or antibiotics. A total of 12 individuals will be enrolled. The study involves four laboratory visits. The first includes an educational workshop on recording diet and exercise, development of an individualized standardized diet, and baseline assessments of body measurements and aerobic performance (peak work rate, heart rate, maximum speed at exhaustion, and VO₂max). The remaining three visits occur 4-5 days apart. In each session, resting physiological measures are recorded, followed by a cycling exercise. Participants then consume the assigned experimental beverage and rest for 210 minutes before completing a second cycling test. Four blood samples are collected per visit at designated time points. Participation is voluntary, and individuals may withdraw at any time. There are no anticipated risks beyond potential discomfort from some questions or procedures. Although participants may not receive direct personal benefit, the findings may contribute to improved understanding of exercise recovery strategies. All collected information will remain confidential, with identifying data stored securely and not included in any publications. Study results will be disseminated through peer-reviewed journals, conferences, and required reports to UAEU's Human Research Ethics Committee and the Research Office. The project is conducted and funded by United Arab Emirates University and has received ethical approval by UAEU Human Ethics Committee on February 7, 2024, (ERH\_2023\_3935).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Apr 2024
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 24, 2026
CompletedMarch 24, 2026
March 1, 2026
1.1 years
March 11, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time to Exhaustion (minutes)
Duration of the cycling-to-exhaustion test recorded in minutes
From enrollment to the end of treatment at 6 hours
Exercise Capacity (workload in watts)
Maximum workload achieved during the post recovery exercise capacity test
From enrollment to the end of treatment at 6 hours
Secondary Outcomes (6)
Heart Rate (beats per minute)
From enrollment to the end of treatment at 6 hours
Rating of Perceived Exertion (RPE units)
From enrollment to the end of treatment at 6 hours
Oxygen Consumption (VO₂; mL·kg-¹·min-¹)
From enrollment to the end of treatment at 6 hours
Carbon Dioxide Production (VCO₂; mL·kg-¹·min-¹)
From enrollment to the end of treatment at 6 hours
Plasma Cytokines (pg/mL)
From enrollment to the end of treatment at 6 hours
- +1 more secondary outcomes
Study Arms (3)
Control
OTHERNo treatment
Camel Milk
EXPERIMENTALReceived camel milk
Cow Milk
EXPERIMENTALReceived cow milk
Interventions
Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).
Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).
Twelve recreationally trained healthy male participants will be recruited to perform three cycling to volitional exhaustion trials followed by 4-hour recovery period and a subsequent exercise capacity test. Following conclusion of the cycling exercise session and within a period of 30 minutes at the start of the recovery period from the cycling exercise, an equal 500 ml volume of either water, cow milk, or camel milk will be consumed in a crossover counterbalanced design. Time to exhaustion, heart rate (HR), rating of perceived exertion (RPE), oxygen consumption, carbon dioxide production, and workload will be recorded per trial. Blood samples will be collected before and after exercise to determine plasma levels of systemic cytokines (IL-6, IL-10, TNF-α) and creatine kinase (CK).
Eligibility Criteria
You may qualify if:
- Recreational athlete
- Active 5 Days a Week
- Male
- Healthy
- Non-Obese
- to 30 years old
- No allergies to milk.
You may not qualify if:
- Sedentary
- Female
- Allergies to milk
- Presence of diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
United Arab Emirates University Building E3 Room 0015
Al Ain City, Abu Dhabi Emirate, 15551, United Arab Emirates
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 24, 2026
Study Start
April 30, 2024
Primary Completion
May 30, 2025
Study Completion
June 1, 2025
Last Updated
March 24, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
To maintain the privacy of the individuals